Categoría: Europe

Auto Agregado por WPeMatico


Aura Health Inc. (CSE:BUZZ) is pleased to announce the signing of master grower, Adrian Richelmi, to build and operate HolyCanna’s 60,000 square foot greenhouse facilty in Israel. Aura is a debt holder of HolyCanna that converts into 54% equity (see Read more…


Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), is pleased to announce that Biocannabix Health Corporation (“Biocannabix”), a wholly-owned subsidiary of Relevium has executed on June 12, 2019 a binding agreement to acquire the shares of Lifeline Pharma Read more…


Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF, Frankfurt:6BX) (the “Company” or “Relevium”), is pleased to announce that it has closed a non-brokered private placement financing for a total of 15,350,000 units (the “Units”) at $0.08 per Unit, for total gross proceeds of $1,228,000. Read more…


Aura Health Inc. (CSE:BUZZ) is pleased to provide an update on its operations and corporate strategy regarding the German medical cannabis market. As announced on May 17, 2019, the Company closed its acquisition of 80% of the equity of Pharmadrug Read more…


Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), is pleased to provide a corporate update on the Company’s positioning and strategy regarding medical cannabis and CBD Nutraceuticals. LEEFYLYFETM BRAND OF HEMP CBD FORMULATIONS United States The Food and Drug Read more…


Aura Health Inc. (CSE:BUZZ) is pleased to announce the appointment of Al Quong to its board of directors, subject to regulatory approval. Mr. Quong is an experienced finance professional, with more than 25 years of operational and advisory experience in Read more…


Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce that its wholly owned subsidiary Biocannabix Health Corporation Inc., has completed necessary compliance process and obligations for the acquisition for exclusive licensing with cannabis company Cannakids®. Read more…


Relevium Technologies Inc. (TSXV:RLV,OTCQB:RLLVF;FWB:6BX)(the “Company” or “Relevium”), is pleased to announce that its OTC business has launched a new line of omega fish oils based formulations targeting inflammation, heart and vision care. High End Omega Based Product Line The Company has launched Read more…


Aura Health Inc. (the “Company” or “Aura”) (CSE:BUZZ) is pleased to announce that it has closed the previously announced (May 8, 2019) acquisition of an 80% equity interest in Pharmadrug Production GmbH (“Pharmadrug”) for total consideration of €5.0 million. Pharmadrug is Read more…


Relevium Technologies Inc. (TSXV:RLV, OTCQB:RLLVF; FWB:6BX) (the “Company” or “Relevium”), announced the re-pricing 12,398,500 warrants series 2017 with an original exercise price of $0.15 and expiring June 16, 2019 and 3,258,000 warrants of series 2016 with an original exercise price of $0.15 Read more…

Weevertising

Categorías